A Randomized, Blinded Placebo-Controlled Study to Evaluate the Effect of Repeat Oral Doses of Pazopanib (GW786034) on the Electrocardiogram (ECG) With Focus on Cardiac Repolarization (QTc Duration) in Subjects With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Moxifloxacin; Pazopanib
- Indications Bacterial infections; Solid tumours
- Focus Pharmacodynamics
- 06 Apr 2010 Actual patient number (96) added, actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 06 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.